MycoAcademy logo

Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

By continuing to view this video or podcast, you confirm that you are a healthcare professional. Mundipharma owns all rights, including copyrights, to this recording. The recording (or any link to it) may not be changed, supplemented or redistributed without the express written consent of Mundipharma.

Laboratory capacity to diagnose invasive fungal infections in Europe

Martin Hoenigl, Cornelia Lass-Flörl and Patricia Muñoz discuss the importance of reference laboratories, how laboratory capacity differs across European countries, and how European laboratory capacity can be improved

SciA-AFN-2400015 | February 2024

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyuk@napp.co.uk.